课题基金 / 基金详情

For a new therapy of Crohn's disease using chronic colitis model in mice.

For a new therapy of Crohn's disease using chronic colitis model in mice.
使用小鼠慢性结肠炎模型开发克罗恩病的新疗法。
批准号:
09670545
负责人:
NAKAMURA Hideji
金额:
$1.66万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998

项目摘要

项目成果

NAKAMURA Hideji的其他基金

相似基金

相关文献

中文摘要
翻译
在日本,克罗恩病患者有所增加,但其发病机制尚未明确。近年来,有报道称Th-1辅助性T细胞在人类克罗恩病的发展和恶化中发挥重要作用。一些化学物质如TNBS和DSS已被证明可诱导大鼠慢性结肠炎。特别是,据报道,tnbs引起的结肠炎类似于人类克罗恩病。因此,我们计划建立小鼠慢性结肠炎模型,为克罗恩病患者开发一种新的治疗工具提供依据。首先,我们尝试采用与大鼠相同的方法,采用TNBS灌肠法建立小鼠慢性结肠炎模型。然而,我们无法成功地在小鼠中发展慢性结肠炎,而不是几种小鼠和几种给药剂量的TNBS。其次,我们选择了腹泻和结肠炎小鼠消耗性疾病模型。该模型通过给药CD4^+CD45RB^<高> T细胞引入,已知在小鼠中显示Th-1细胞介导的结肠炎。利用磁珠和流式细胞术从脾淋巴细胞中分选CD4^+CD45RB^<高> T细胞后,将部分CD4^+CD45RB^<高> T细胞腹腔注射Balb/c SCID小鼠。注射后3 ~ 4周出现腹泻,8周左右体重逐渐下降至注射前体重的10%以下。组织学检查显示肠黏膜增厚、杯状细胞抑制、单核细胞浸润。粘膜组织中ifn - γ和IL-6 mRNA的表达明显升高。因此,我们试图阐明抗小鼠IL-6受体单克隆抗体(aIL6RmAb)对慢性结肠炎模型小鼠结肠炎和体重减轻的影响。有趣的是,在注射CD4^+CD45RB^<高> T细胞后,通过每周腹腔注射aIL6RmAb (1mg/小鼠),aIL6RmAb可以防止由CD4^+CD45RB^<高> T细胞引入的小鼠出现腹泻和体重减轻。aIL6RmAb抑制粘膜增生和炎症,并抑制粘膜中ifn - γ的表达。这些结果提示,aIL6RmAb可能成为克罗恩病患者的有效治疗工具。在注射CD4^+CD45RB^<高> T细胞的小鼠发生结肠炎后,需要进一步研究aIL6RmAb对其在克罗恩病患者中的应用。少
英文摘要
The patients with Crohn's disease have increased in Japan, but its pathogenesis has not yet been clarified.Recently, Th-1 helper T cells have been reported to play important roles on the development and exacerbation of Crohn's disease in human.Some chemicals such as TNBS and DSS bye been shown to induce chronic colitis in Rat.Especially, it is reported that TNBS-induced colitis resembles to human Crohn's disease.Therefore, we planned to develope chronic colitis model in mice, to make use of for the developemnet of a new therapeutic tool for the patients with Crohn's disease.First, we tried to develope chronic colitis model in mice by TNBS enema, in the same method as that used for rat.However, we could not succeed in the developement of chronic colitis in mice, instead of several species of mouse and several administration doses of TNBS.Next, we selected wasting disease model with diarrhea and colitis in mice.This model, which is introduced by administration of CD4^+CD45RB^<high> T cel … More ls, is known to show Th-1 cell mediated colitis in mice.After sorting CD4^+CD45RB^<high> T cells from splenic lymphocytes using magnet bead and FACS, a fraction of CD4^+CD45RB^<high> T cells was injected intraperitoneally into Balb/c SCID mouse.Diarrhea appeared about 3-4 weeks after injection and body weight decreased gradually to the level of 10% below before injection in about 8 weeks, in comparison to the increase of body weight in control mice.Histological examination revealed mucosal hyperpiasia, goblet cell depression and mononuclear cell infiltration in intestinal mucosa.The expression of IFN-gamma and IL-6 mRNA in the mucosa was significantly elevated.Thus, we tried to elucidate the effect of anti-mouse IL-6 receptor monoclonal antibody (aIL6RmAb) on the colitis and body weight loss in this chronic colitis model In mice.Interestingly, aIL6RmAb prevented the appearance of diarrhea and body weigt loss in mice introduced by CD4^+CD45RB^<high> T cells, by the administration of aIL6RmAb (1mg/mouse) intraperitoneally weekly since the injection of CD4^+CD45RB^<high> T cells.The aIL6RmAb prevented the mucosal hyperplasia and inflammation and also inhibited the expressoin of IFN-gamma in the mucosa.These results suggest that aIL6RmAb may become a useful therapeutic tool for the patients with Crohn's disease.Further examination of the effect of aIL6RmAb after the occurrence of colitis in mice injected CD4^+CD45RB^<high> T cells will be needed for its application to the patients with Crohn's disease. Less
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
小川 弘之 他: "クローン病腸粘膜におけるT細胞受容体Vβレパトアの解析" 消化器と免疫. 29. 106-111 (1994)
Hiroyuki Okawa 等人:“克罗恩病肠粘膜中 T 细胞受体 Vβ 的分析”《胃肠病学和免疫学》29. 106-111 (1994)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
H.Ogawa.et al: "Univrsal Skew of T cell Receptor Vβ Usage for Crohns Disease" Biophys.Biochem.Res.Comm.240. 545-551 (1997)
H.Okawa.等人:“克罗恩病中 T 细胞受体 Vβ 使用的普遍偏差”Biophys.Biochem.Res.Comm.240 (1997)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ogawa,H.et al.: "Universal Skew of T Cell Receptor for Vβ Usage for Crohn's Disease." Biochem.Biophys.Res.Comm.240. 545-551 (1997)
Okawa, H. 等人:“T 细胞受体用于治疗克罗恩病的 Vβ 的普遍偏差。”Biochem.Biophys.Res.Comm.240(1997)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
金澤 済江: "Crohn病腸管におけるIL-6,TNF-αの発現に関する研究" 大阪大学医学雑誌. 50(1). 33-42 (1998)
Saie Kanazawa:“克罗恩病肠道中IL-6和TNF-α表达的研究”大阪大学医学杂志50(1)(1998)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Growth suppression of hepatocellular carcinoma by the regulation of the expression and activation of hepatoma-derived growth factor and its receptor
  • 批准号:
    19590795
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.91万
  • 财政年份:
    2007
  • 负责人:
    NAKAMURA Hideji
  • 依托单位:
Roles of Hepatoma-derived growth factor(HDGF) on the proliferation and differentiation of hepatic stem cells and liver development
  • 批准号:
    15590699
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.24万
  • 财政年份:
    2003
  • 负责人:
    NAKAMURA Hideji
  • 依托单位:
Roles of hepatoma-derived growth factor (HDGF) on liver development, regeneration and hepatocellular carcinogenesis
  • 批准号:
    12670484
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.18万
  • 财政年份:
    2000
  • 负责人:
    NAKAMURA Hideji
  • 依托单位:
海外基金